The latest analysts believe the GLP-1 market will surpass $150 billion by 2030, mainly due to changes in production, competition, and access
Its too early to know if too much B12, based on high levels from a blood test, is a health concern
The medication shows promising effects in this area as well
At this point, we dont have strong evidence that GLP-1 medications reduce progesterones effectiveness, but if youre noticing changes in sleep, breakthrough bleeding, or the return of symptoms after starting a GLP-1, dont assume your hormones have suddenly stopped working
We also recommend studies to evaluate the potential side effects of taking semaglutide long-term among those with obesity or diabetes, as well as other at-risk populations, she says
As these medications target more metabolic pathways simultaneously, the interaction with dietary ketosis becomes more nuanced and potentially more powerful